Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Outsourcing Grows in Europe

August 1, 2014

Pharmaceutical Technology Europe

Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years.

Quality by Design in Contract Service Relationships

August 1, 2014
Pharmaceutical Technology

Contract service providers describe how quality by design has influenced a drug sponsor's expectations of suppliers.

Weighing Clinical Trial Outsourcing Options

August 1, 2014

Pharmaceutical Technology

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.

Solid-Dosage Forms Demand Traditional and Emerging Technologies

August 1, 2014
Pharmaceutical Technology

Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.

Contractors Invest in Capacity and Capabilities

August 1, 2014
Pharmaceutical Technology

Contract research, development, and manufacturing organizations invested in new facilities and technologies in 2014 for analytical testing, as well as small- and large-molecule drug development.

Positive Outlook for Outsourcing

August 1, 2014

Pharmaceutical Technology

Contract services ride high as funding floods bio/pharma.

Analytical Labs Strive to Deliver More Information, Faster

August 1, 2014
Pharmaceutical Technology

Experts from contract testing laboratories and service organizations shared their perceptions of analytical testing advances, and challenges still ahead.

CMOs Target Parenteral Drug Development Needs Both Large and Small

August 1, 2014
Pharmaceutical Technology

Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.

Shifting Gears in Drug Development Outsourcing Responsibilities

August 1, 2014

Pharmaceutical Technology

For a bio/pharma industry in flux, contract services are playing a greater—and more diverse—role in drug development.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here